Artivion Inc (AORT) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide.

Total Assets Chart for Artivion Inc

Artivion Inc (AORT) total assets for FY2025 were USD 884.8M, a 12.1% change from FY2024. Artivion Inc's total assets grew from USD 10.9M in 1991 to USD 884.8M in 2025 (8017.4% over 34 years). Total assets compound annual growth rate: 5-year CAGR of 2.3%, 10-year CAGR of 17.2%, 20-year CAGR of 13.0%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$1.14B
Implied Share Price
$23.30
Enterprise Value
$1.49B
Revenue (TTM)
$471.47M
EBITDA
$63.72M
Profit Margin
-0.67%
Trailing P/E
—
Forward P/E
35.97
Price/Book (MRQ)
2.61
Price/Sales (TTM)
2.41
EV/EBITDA
29.28
EV/Revenue
3.17
Dividend Yield
—
Book Value
$9.15
Free Cash Flow (FY2025)
-$911,000.00
Free Cash Flow Yield
-0.08%

Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.